Cibus

CBUS · NASDAQ

$1.39+$0.08 (+6.11%)TodayMarket closed ·
Prev close $1.31

About CBUS

Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California and currently employs 118 full-time employees. The company went IPO on 2017-07-20. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). The company is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. The company has a pipeline of five productivity traits. The company has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.

Employees
118
Headquarters
San Diego, California
Listed
Jul 20, 2017
Sector
Health Care
Industry
Biotechnology
Website
cibus.com

Leadership

Cibus executives
NameTitleSince
Rory Riggs—2023
Peter Beetham—2023
Greg Gocal——
Cornelis Broos——
Noel Sauer——
Jason Stokes——
Mark Finn——
Kimberly Box——
Craig Wichner——
Jean-Pierre Lehmann——
August Moretti——
Gerhard Prante——
Keith Walker——

Similar companies

Companies in the same industry as Cibus

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.